CDDP, 5 Fu

DRUG2 trials

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris, Gruppo Oncologico del Nord-Ovest

Conditions

Gastroesophageal AdenocarcinomaHypopharynx CancerLarynx CancerOral CancerOropharynx Cancer

Phase 2

Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCC

CompletedNCT00162708

Gustave Roussy, Cancer Campus, Grand ParisOropharynx Cancer, Oral Cancer, Hypopharynx Cancer +1

Start: 1996-07-01Target: 120Updated: 2026-08-19

Phase 3

Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinoma

Not yet recruitingNCT07763171

Gruppo Oncologico del Nord-OvestGastroesophageal Adenocarcinoma

Start: 2026-09-01End: 2031-09-01Target: 244Updated: 2026-08-18